• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BLIMP-1介导浆细胞中主要组织相容性复合体II类反式激活因子表达的消减。

BLIMP-I mediates extinction of major histocompatibility class II transactivator expression in plasma cells.

作者信息

Piskurich J F, Lin K I, Lin Y, Wang Y, Ting J P, Calame K

机构信息

Lineberger Comprehensive Cancer Center, Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

出版信息

Nat Immunol. 2000 Dec;1(6):526-32. doi: 10.1038/82788.

DOI:10.1038/82788
PMID:11101876
Abstract

Class II transactivator (CIITA), a coactivator required for class II major histocompatibility complex (MHC) transcription, is expressed in B cells but extinguished in plasma cells. This report identifies B lymphocyte-induced maturation protein I (BLIMP-I), a transcriptional repressor that is capable of triggering plasma cell differentiation, as a developmentally regulated repressor of CIITA transcription. BLIMP-I represses the B cell-specific promoter of the human gene that encodes CIITA (MHC2TA) in a binding site-dependent manner. Decreased CIITA correlates with increased BLIMP-I during plasma cell differentiation in cultured cells. Ectopic expression of BLIMP-I represses endogenous mRNA for CIITA and the CIITA targets, class II MHC, invariant chain and H2-DM (the murine equivalent of HLA-DM) in primary splenic B cells as well as 18-81 pre-B cells. Thus, the BLIMP-I program of B cell differentiation includes loss of antigen presentation via extinction of CIITA expression.

摘要

II类反式激活因子(CIITA)是II类主要组织相容性复合体(MHC)转录所需的一种共激活因子,在B细胞中表达,但在浆细胞中消失。本报告鉴定出B淋巴细胞诱导成熟蛋白I(BLIMP-I),一种能够触发浆细胞分化的转录抑制因子,是CIITA转录的发育调控抑制因子。BLIMP-I以结合位点依赖的方式抑制编码CIITA(MHC2TA)的人类基因的B细胞特异性启动子。在培养细胞的浆细胞分化过程中,CIITA的减少与BLIMP-I的增加相关。BLIMP-I的异位表达抑制了原代脾B细胞以及18-81前B细胞中CIITA的内源性mRNA以及CIITA的靶标II类MHC、恒定链和H2-DM(小鼠等同物HLA-DM)。因此,B细胞分化的BLIMP-I程序包括通过CIITA表达的消失而丧失抗原呈递。

相似文献

1
BLIMP-I mediates extinction of major histocompatibility class II transactivator expression in plasma cells.BLIMP-1介导浆细胞中主要组织相容性复合体II类反式激活因子表达的消减。
Nat Immunol. 2000 Dec;1(6):526-32. doi: 10.1038/82788.
2
Active suppression of the class II transactivator-encoding AIR-1 locus is responsible for the lack of major histocompatibility complex class II gene expression observed during differentiation from B cells to plasma cells.II类反式激活因子编码基因AIR-1位点的主动抑制,是B细胞向浆细胞分化过程中观察到的主要组织相容性复合体II类基因表达缺失的原因。
Eur J Immunol. 1996 Oct;26(10):2456-60. doi: 10.1002/eji.1830261028.
3
Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.检测慢性淋巴细胞白血病中主要组织相容性复合体II类抗原呈递基因的异常转录,发现HLA-DOA mRNA是生存的一个预后因素。
Br J Haematol. 2009 May;145(3):334-43. doi: 10.1111/j.1365-2141.2009.07625.x. Epub 2009 Feb 24.
4
Impaired class II transactivator expression in mice lacking interferon regulatory factor-2.缺乏干扰素调节因子-2的小鼠中II类反式激活因子表达受损。
Oncogene. 2001 Jul 12;20(31):4219-27. doi: 10.1038/sj.onc.1204556.
5
Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation.在爱泼斯坦-巴尔病毒重新激活期间,裂解性反式激活因子Zta通过抑制CIITA转录来下调MHC II类分子的表达。
J Immunol. 2009 Feb 15;182(4):1799-809. doi: 10.4049/jimmunol.0802686.
6
Collagen and major histocompatibility class II expression in mesenchymal cells from CIITA hypomorphic mice.CIITA低表达小鼠间充质细胞中胶原蛋白和主要组织相容性复合体II类的表达
Mol Immunol. 2007 Mar;44(7):1709-21. doi: 10.1016/j.molimm.2006.07.294. Epub 2006 Sep 18.
7
Positive regulatory domain I-binding factor 1 mediates repression of the MHC class II transactivator (CIITA) type IV promoter.正向调节域I结合因子1介导对MHC II类反式激活因子(CIITA)IV型启动子的抑制作用。
Mol Immunol. 2007 Feb;44(6):1461-70. doi: 10.1016/j.molimm.2006.04.026. Epub 2006 Jun 12.
8
Discoordinate surface expression of IFN-gamma-induced HLA class II proteins in nonprofessional antigen-presenting cells with absence of DM and class II colocalization.在缺乏DM且II类分子不共定位的非专职抗原呈递细胞中,IFN-γ诱导的HLA II类蛋白的表面表达失调。
J Immunol. 1998 Apr 1;160(7):3207-16.
9
Class II transactivator promoter activity is suppressed through regulation by a trophoblast noncoding RNA.II类反式激活因子启动子活性通过滋养层非编码RNA的调控而受到抑制。
Transplantation. 2003 Jul 27;76(2):387-94. doi: 10.1097/01.TP.0000073612.04525.46.
10
MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?小鼠肿瘤中的MHC II类抗原呈递途径:肿瘤对免疫监视的逃避?
Br J Cancer. 2000 Nov;83(9):1192-201. doi: 10.1054/bjoc.2000.1415.

引用本文的文献

1
Blocking plasma cell fate enhances antigen-specific presentation by B cells to boost anti-tumor immunity.阻断浆细胞命运可增强B细胞的抗原特异性呈递,从而增强抗肿瘤免疫力。
Nat Commun. 2025 May 14;16(1):4454. doi: 10.1038/s41467-025-59622-4.
2
-epigenomic reprogramming and maintenance of plasma cell phenotype in t(4;14) myeloma.t(4;14) 骨髓瘤中浆细胞表型的表观基因组重编程与维持
Oncotarget. 2025 Mar 21;16:220-229. doi: 10.18632/oncotarget.28706.
3
BHLHE41, a transcriptional repressor involved in physiological processes and tumor development.
BHLHE41,一种参与生理过程和肿瘤发展的转录抑制因子。
Cell Oncol (Dordr). 2025 Feb;48(1):43-66. doi: 10.1007/s13402-024-00973-3. Epub 2024 Sep 10.
4
Blunting specific T-dependent antibody responses with engineered "decoy" B cells.利用工程化“诱饵”B 细胞来钝化特定的 T 依赖性抗体反应。
Mol Ther. 2024 Oct 2;32(10):3453-3469. doi: 10.1016/j.ymthe.2024.08.023. Epub 2024 Aug 26.
5
KSHV infection of B cells primes protective T cell responses in humanized mice.卡波西肉瘤相关疱疹病毒(KSHV)感染 B 细胞可在人源化小鼠中引发保护性 T 细胞应答。
Nat Commun. 2024 Jun 6;15(1):4841. doi: 10.1038/s41467-024-49209-w.
6
Casting Light on the Janus-Faced HMG-CoA Reductase Degradation Protein 1: A Comprehensive Review of Its Dualistic Impact on Apoptosis in Various Diseases.揭示两面神 HMG-CoA 还原酶降解蛋白 1 的真面目:其在多种疾病中对细胞凋亡的双重影响的全面综述。
Mol Neurobiol. 2024 Sep;61(9):6842-6863. doi: 10.1007/s12035-024-03994-z. Epub 2024 Feb 14.
7
The NLR member CIITA: Master controller of adaptive and intrinsic immunity and unexpected tool in cancer immunotherapy.NLR 成员 CIITA:适应性和固有免疫的主控器以及癌症免疫治疗中的意外工具。
Biomed J. 2023 Oct;46(5):100631. doi: 10.1016/j.bj.2023.100631. Epub 2023 Jul 17.
8
Regulation of the antigen presentation machinery in cancer and its implication for immune surveillance.肿瘤中抗原呈递机制的调控及其对免疫监视的影响。
Biochem Soc Trans. 2022 Apr 29;50(2):825-837. doi: 10.1042/BST20210961.
9
The Immunogenetics of Systemic Sclerosis.系统性硬化症的免疫遗传学。
Adv Exp Med Biol. 2022;1367:259-298. doi: 10.1007/978-3-030-92616-8_10.
10
Immunogenetics of Lupus Erythematosus.红斑狼疮的免疫遗传学。
Adv Exp Med Biol. 2022;1367:213-257. doi: 10.1007/978-3-030-92616-8_9.